Clinical Trials

Showing trials with last updates posted in 2026.

NCT04539366 | SUSPENDED | PHASE1
73 participants

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2022-01-25
Completion:
2040-12-31
Conditions
  • Recurrent Childhood Neuroblastoma
  • Recurrent Childhood Osteosarcoma
  • Recurrent Neuroblastoma
  • Recurrent Osteosarcoma
  • Refractory Childhood Neuroblastoma
  • Refractory Childhood Osteosarcoma
  • Refractory Neuroblastoma
  • Refractory Osteosarcoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT03367169 | TERMINATED | NA
54 participants

Surgery of the Pilon Fractures

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2017-11-23
Completion:
2024-04-26
Conditions
  • Pilon Fractures
  • Fractures
  • Bone
  • Leg Injuries
Interventions
  • PROCEDURE
No Results Yet
NCT03026062 | COMPLETED | PHASE2
100 participants

Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2017-05-18
Completion:
2025-09-11
Conditions
  • Platinum-Resistant Fallopian Tube Carcinoma
  • Platinum-Resistant Ovarian Carcinoma
  • Platinum-Resistant Primary Peritoneal Carcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Refractory Fallopian Tube Carcinoma
  • Refractory Ovarian Carcinoma
  • Refractory Primary Peritoneal Carcinoma
Interventions
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page